COVID-19 pandemic shifted epidemiology for cancer screening sites: breast, cervix, colon, and rectum
Ishkinin Y. Kaidarova D. Nazarbek S. Zhylkaidarova A. Ossikbayeva S. Mussina K. Omarbayeva N.
2024Frontiers Media SA
Frontiers in Oncology
2024#14
Background: This study aimed to assess the epidemiological changes in breast, cervical, colon, and rectal cancers in Kazakhstan before and during COVID-19, including early-onset cancer (EOC) diagnosed between the ages of 20 and 49, using data from the oncological service of the Republic of Kazakhstan for the 2017–2022 period. Methods: The cohort comprised patients aged 20 to 49 years (EOC) and 50 years and older [late-onset cancer (LOC)] from the total number of patients diagnosed each year during the study period of 2017 to 2022 for breast, cervical, colon, or rectal cancer. In order to indicate a difference in one-time intervals and characterize the global trend over the entire study period, annual percentage change (APC) and average APC (AAPC) were calculated, respectively. Results: Breast cancer detection rates increased by 22.8% for EOC and 15.9% for LOC from 2017 to 2022, and AAPC increased by 4.3% for EOC and 3.6% for LOC. During the COVID-19 restriction period, breast cancer detection rates decreased by 6.1% for EOC and 15.6% for LOC. Cervical cancer detection rates increased by 2.3% for EOC and 7.5% for LOC from 2017 to 2022, and AAPC increased by 0.9% for EOC and 1.6% for LOC. During the COVID-19 restriction period, cervical cancer detection rates decreased by 11.3% for EOC and 3.1% for LOC. Colon cancer detection rates increased by 18.4% for EOC and 14.3% for LOC from 2017 to 2022, and AAPC increased by 3.7% for EOC and 2.9% for LOC. During the COVID-19 restriction period, colon cancer detection rates decreased by 14.4% for EOC and 5.8% for LOC. Rectal cancer detection rates increased by 13.6% for EOC and 19.2% for LOC from 2017 to 2022, and AAPC increased by 3.0% for EOC and by 3.9% for LOC. During the COVID-19 restriction period, rectal cancer detection rates increased by 18.6% for EOC and decreased by 12.0% for LOC. Conclusion: The epidemiological indicators of population cancer screening worsened during the COVID pandemic; the detection rate decreased by 6.1% for breast EOC and 11.3% for cervical EOC, while there was an increase by 38.0% in EOC for colon cancer in men and by 8.0% in EOC for rectal cancer in men and 31.1% in women. Copyright
breast cancer , cancer screening , cervical cancer , colon cancer , COVID-19 , early-onset cancer , rectum cancer
Text of the article Перейти на текст статьи
Department of Radiation Therapy, Almaty Oncology Center, Almaty, Kazakhstan
Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
Asfendiyarov Kazakh National Medical University, Almaty, Kazakhstan
Club of Experts under the Senate of Republic of Kazakhstan, Astana, Kazakhstan
Kazakhstan Association of Healthcare Managers, Astana, Kazakhstan
Department of Screening, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
Centre for Molecular Genetic Research, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
Department of Medicine, School of Medicine, Nazarbayev University, Astana, Kazakhstan
Department of Mammology, Kazakh Institute of Oncology and Radiology, Almaty, Kazakhstan
Department of Radiation Therapy
Kazakh Institute of Oncology and Radiology
Asfendiyarov Kazakh National Medical University
Club of Experts under the Senate of Republic of Kazakhstan
Kazakhstan Association of Healthcare Managers
Department of Screening
Centre for Molecular Genetic Research
Department of Medicine
Department of Mammology
10 лет помогаем публиковать статьи Международный издатель
Книга Публикация научной статьи Волощук 2026 Book Publication of a scientific article 2026